跳至主要内容
临床试验/CTRI/2019/01/017089
CTRI/2019/01/017089招募中未知

A prospective, observational, Multicenter study to evAluate safety and effIcacy of cilniDipine, mEtoprolol succinate and chlorthalidoNe in high risk hypertensive patients

Aprica Healthcare Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients willing to provide written informed consent form
  • 2.Male or Female patients aged 18 years and above
  • 3.Essential hypertension which is uncontrolled (defined as systolic BP >= 140 mmHg or diastolic BP >= 90 mmHg ) on dual anti-hypertensive agents
  • 4.Patients treated with cilnidipine, metoprolol succinate and chlorthalidone

排除标准

  • 1. Patients receiving any other antihypertensive other than cilnidipine, metoprolol succinate and chlorthalidone

研究者

发起方
Aprica Healthcare Pvt Ltd

相似试验